204 related articles for article (PubMed ID: 33487072)
1. MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4.
Cai L; Ye L; Hu X; He W; Zhuang D; Guo Q; Shu K; Jie Y
Bioengineered; 2021 Dec; 12(1):440-449. PubMed ID: 33487072
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR-493-3p suppresses ovarian cancer cell proliferation, migration and invasion through downregulating DPY30.
Liu Q; Yang H; Hua H
Reprod Biol; 2022 Jun; 22(2):100610. PubMed ID: 35313261
[TBL] [Abstract][Full Text] [Related]
3. The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p.
Wang L; Ren C; Xu Y; Yang L; Chen Y; Zhu Y
J Ovarian Res; 2021 Jun; 14(1):77. PubMed ID: 34116704
[TBL] [Abstract][Full Text] [Related]
4. microRNA-324-3p suppresses the aggressive ovarian cancer by targeting
Li F; Liang Z; Jia Y; Zhang P; Ling K; Wang Y; Liang Z
Bioengineered; 2022 May; 13(5):12030-12044. PubMed ID: 35549643
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
7. Receptor interacting protein kinase 4 promotes cell proliferation, migration, and invasion in ovarian cancer via targeting protein kinase C delta.
Jin A; Zhang L; Fang G; Chen Y
Drug Dev Res; 2022 Apr; 83(2):407-415. PubMed ID: 34414590
[TBL] [Abstract][Full Text] [Related]
8. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-134-3p inhibits ovarian cancer progression by targeting flap structure-specific endonuclease 1 in vitro.
Zhao M; Ji H; Fu Q; Cheng Q; Zhang Y; Yang Y
Oncol Rep; 2021 Jan; 45(1):119-128. PubMed ID: 33169800
[TBL] [Abstract][Full Text] [Related]
10. MiR-5195-3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer.
Wang Z; Zhang X; Liu Y; Shi X; Li L; Jia Y; Wu F; Cui H; Li L
Histol Histopathol; 2023 Dec; 38(12):1403-1413. PubMed ID: 36825753
[TBL] [Abstract][Full Text] [Related]
11. MiR-655-3p inhibited proliferation and migration of ovarian cancer cells by targeting RAB1A.
Zha JF; Chen DX
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3627-3634. PubMed ID: 31114987
[TBL] [Abstract][Full Text] [Related]
12. Study on the Function and Mechanism of miR-585-3p Inhibiting the Progression of Ovarian Cancer Cells by Targeting FSCN1 to Block the MAPK Signaling Pathway.
Jia Y; Li J; Wang J; Luo T; Jing X; Zhao H
Anal Cell Pathol (Amst); 2022; 2022():1732365. PubMed ID: 35602576
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression.
Jiang R; Zhang H; Zhou J; Wang J; Xu Y; Zhang H; Gu Y; Fu F; Shen Y; Zhang G; Feng L; Zhang X; Chen Y; Shen F
Cell Death Dis; 2021 Feb; 12(2):145. PubMed ID: 33542185
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis.
Liu T; Yuan L; Zou X
J Ovarian Res; 2022 Aug; 15(1):95. PubMed ID: 35965327
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway.
Xia XY; Yu YJ; Ye F; Peng GY; Li YJ; Zhou XM
Neoplasma; 2020 Mar; 67(2):344-353. PubMed ID: 31973537
[TBL] [Abstract][Full Text] [Related]
16. PARP1 Is Targeted by miR-519a-3p and Promotes the Migration, Invasion, and Tube Formation of Ovarian Cancer Cells.
Chang H; Zhang X; Li B; Meng X
Cancer Biother Radiopharm; 2022 Nov; 37(9):824-836. PubMed ID: 34009012
[No Abstract] [Full Text] [Related]
17. miR-205-3p Functions as a Tumor Suppressor in Ovarian Carcinoma.
Qiao B; Wang Q; Zhao Y; Wu J
Reprod Sci; 2020 Jan; 27(1):380-388. PubMed ID: 32046433
[TBL] [Abstract][Full Text] [Related]
18. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.
Zheng J; Zhou Y; Li XJ; Hu JM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483
[TBL] [Abstract][Full Text] [Related]
19. LINC00665 affects the malignant biological behavior of ovarian cancer via the miR-148b-3p/KLF5.
Wang S; Liu C; Li Y; Qiao J; Chen X; Bao J; Li R; Xing Y
Syst Biol Reprod Med; 2022; 68(5-6):370-383. PubMed ID: 36016468
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of lncRNA HCG11 suppresses cell progression in ovarian cancer by modulating miR-144-3p/PBX3.
Li XF; Hu DM; Zhao YX; Zhang L; Jin Y
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11032-11040. PubMed ID: 33215418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
